Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Average Price Target from Analysts
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been assigned an average recommendation of “Buy” ...
D. Boral Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They currently ...
ONS-5010 shows promise in wet AMD treatment, matching Lucentis
ISELIN, N.J. - Outlook Therapeutics, Inc. (NASDAQ:OTLK), a clinical-stage biopharmaceutical company with a current market capitalization of $52 million, reported at the Hawaiian Eye and Retina 2025 ...
UBX stock touches 52-week high at $2.02 amid market optimism
Unity Biotechnology Inc (NASDAQ:UBX) stock has reached a 52-week high, trading at $2.02, signaling a period of robust ...